Circumcision — Cost, Top Hospitals & Success Rates | MyMedicPlus

Circumcision is the surgical removal of the prepuce (foreskin) — the retractile sleeve of skin and mucosal tissue that covers and protects the glans penis. It is one of the oldest and most commonly performed surgical procedures in the world, performed across diverse cultural, religious, and medical contexts.

From a medical standpoint, circumcision has several established and evidence-based indications, as well as several contexts where it is performed without a strictly medical reason (ritual, cultural, or parental preference). The distinction between medically indicated and elective circumcision carries ethical and clinical significance.

The procedure is performed differently depending on the patient's age:

• Neonatal circumcision (newborn to 2 months): typically performed with a specialised clamp device (Mogen, Plastibell, or Gomco) under local anaesthesia, usually by an obstetrician, paediatrician, or trained religious practitioner
• Paediatric circumcision (children 2 months to 15 years): typically performed under general anaesthesia by a paediatric urologist or paediatric surgeon
• Adult circumcision: performed under local or spinal anaesthesia, or general anaesthesia, by a urologist or general surgeon using sleeve resection or dorsal slit techniques

The global prevalence of male circumcision is approximately 37–39% (World Health Organization data). Prevalence is highest in Muslim-majority countries (>90%), the United States (~70–80%), Israel (>90%), and sub-Saharan Africa (varies by culture). In Western Europe, Australia, and most of Asia, routine neonatal circumcision rates are much lower (2–20%).

Medical societies internationally have different positions: the American Academy of Pediatrics (AAP 2012) concluded that the benefits of newborn male circumcision outweigh the risks for at-risk groups (Grade B recommendation), while the British Medical Association (BMA), Royal Australasian College of Physicians (RACP), and Royal Dutch Medical Association advise that non-therapeutic circumcision of minors should require demonstrable medical benefit.

Circumcision has several established medical indications where the procedure addresses a specific pathological or risk-reducing purpose.

Phimosis

Phimosis is the inability to retract the foreskin over the glans. It is classified using the Kikiros scale (Grade 0 = full retraction; Grade 5 = pinhole meatus). Physiological phimosis is normal in infants and children (90% non-retractile at birth, 90% retractile by age 17) and requires no treatment. Pathological phimosis is caused by balanitis xerotica obliterans (BXO) / lichen sclerosus, a progressive fibrotic skin condition causing white, sclerotic scarring of the foreskin and sometimes the glans and urethral meatus. BXO is the clearest surgical indication for circumcision. Conservative treatment with betamethasone 0.05% or mometasone cream applied daily for 4–8 weeks can achieve retraction in 70–90% of non-BXO physiological phimosis cases and should always be tried first in children.

Paraphimosis

Paraphimosis occurs when a retracted foreskin cannot be reduced back over the glans, causing a constricting band that impairs venous return and leads to painful oedema of the glans and foreskin distal to the band. This is a urological emergency. Initial management is manual reduction (compress the oedematous glans while sliding the foreskin forward) with or without hyaluronidase injection to facilitate oedema reduction. Failed reduction requires a dorsal slit procedure in the emergency department. Elective circumcision is advised after recovery to prevent recurrence.

Recurrent Balanoposthitis

Balanoposthitis (inflammation of the glans and foreskin) that recurs frequently (≥3 episodes per year) despite treatment with topical antifungals (for Candida, the most common organism), antibiotics, or anti-inflammatories is an indication for circumcision. In diabetic men, recurrent Candidal balanoposthitis is particularly common and difficult to control without circumcision combined with glycaemic optimisation.

Recurrent Urinary Tract Infections (UTIs)

The AAP 2012 statement (Grade B evidence) acknowledges that circumcision reduces UTI incidence in boys by approximately 90% (from ~1% to ~0.1% over the first year of life). The benefit is most clinically relevant in boys with underlying urinary tract anomalies (vesicoureteric reflux, posterior urethral valves, pelviureteric junction obstruction) where recurrent UTIs can cause renal scarring. For otherwise healthy boys, the absolute UTI risk reduction is small.

HIV and STI Risk Reduction

Three landmark randomised controlled trials in sub-Saharan Africa (the ANRS 1265 trial in South Africa, the RCTC trial in Uganda, and the UNIM trial in Kenya, all published 2005–2007) demonstrated that male circumcision reduces female-to-male HIV transmission by approximately 60%. The WHO and UNAIDS issued a joint recommendation in 2007 supporting voluntary medical male circumcision (VMMC) as part of comprehensive HIV prevention in high-prevalence, low-circumcision settings (eastern and southern Africa). Circumcision also reduces risk of human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2), and chancroid transmission.

Penile Cancer Prevention

Penile squamous cell carcinoma is rare in circumcised men. Phimosis (an independent risk factor), HPV infection, and smegma accumulation under the foreskin are all implicated in penile carcinogenesis. Circumcision essentially eliminates risk of squamous cell carcinoma of the inner prepuce and glans in men circumcised in infancy. However, penile cancer is rare enough in developed countries (incidence 1 per 100,000 men) that it does not by itself justify routine neonatal circumcision.

Eligibility for circumcision depends on the indication (medical or non-medical), the patient's age and health status, and — for children — the informed consent framework.

Neonatal and Paediatric Eligibility

• Healthy newborns are eligible for circumcision when parents (after informed consent) wish to proceed. The AAP states the benefits outweigh risks for at-risk groups but notes the procedure is not universally recommended for all newborns
• Infants who are unstable, premature, or have significant genitourinary anomalies (hypospadias, epispadias, buried penis, penile torsion) should not be circumcised until anomalies are fully evaluated by a paediatric urologist, as the foreskin tissue may be needed for surgical reconstruction
• Children with pathological phimosis (BXO/lichen sclerosus confirmed) who have failed 4–8-week topical steroid treatment are candidates for circumcision under general anaesthesia
• Boys with recurrent UTIs and underlying urinary tract anomalies, managed with a paediatric nephrologist or urologist

Adult Eligibility

• Any adult male with BXO-related phimosis, recurrent balanoposthitis, paraphimosis history, or requesting circumcision for cultural or personal reasons, without contraindications to anaesthesia
• Adults enrolled in VMMC programmes in high-HIV-prevalence settings per WHO 2007 recommendation
• Pre-operative fitness assessment (anaesthesia risk stratification, coagulation screen, blood count)

Contraindications

• Hypospadias: Foreskin needed for urethral reconstruction — circumcision must be deferred
• Ambiguous genitalia or intersex conditions requiring specialist evaluation
• Coagulopathy (haemophilia, thrombocytopaenia) — relative contraindication; requires haematology co-management
• Active genital infection at the time of surgery — defer until resolved
• Unfitness for anaesthesia — manage medically where possible

Ethical Framework for Non-Medical Circumcision

In children who lack capacity to consent, non-therapeutic circumcision must balance parental rights and cultural/religious freedom against the child's right to bodily integrity. The BMA, RACP, and AAP all acknowledge parental authority to make this decision, while emphasising that the procedure is not risk-free and the choice should be made with full medical information. Adult males can make their own autonomous decision regarding elective circumcision.

Several circumcision techniques are in common use. The choice depends on patient age, operator training, clinical setting, and patient preference.

Neonatal Clamp Methods

Performed with local anaesthesia using a dorsal penile nerve block (DPNB) with 1% lidocaine injected at the 10 o'clock and 2 o'clock positions at the base of the penis, and/or EMLA cream (topical lidocaine/prilocaine) applied 1 hour before the procedure. Sucrose pacifier provides additional comfort. Three main devices are used:

• Gomco clamp: A bell is placed under the foreskin over the glans; a matching plate is applied above; the clamp is tightened to compress the foreskin and provide haemostasis while the excess skin is cut with a scalpel. Takes 5–10 minutes
• Plastibell device: A plastic ring with a handle; string is tied around the foreskin over the ring to cut off blood supply, and the foreskin separates within 5–10 days as it becomes ischaemic and falls off with the plastic ring. No cutting is needed at the time of the procedure
• Mogen clamp: A flat clamp with a curved slot applied over the foreskin; the foreskin is clamped and excised. Very fast (<2 minutes) but associated with rare glans amputation injury if glans is inadvertently drawn into the slot

Dorsal Slit Procedure

Used in emergency paraphimosis (unable to reduce manually) and as a preparatory step for adult circumcision. A full-thickness cut along the dorsal midline of the foreskin releases the constricting band and provides immediate relief. Definitive circumcision is performed electively thereafter.

Adult Sleeve Resection (Freehand Circumcision)

The most commonly performed adult technique:

1. Mark the inner and outer foreskin excision lines with a marking pen (to determine the amount of skin to remove and the aesthetic position of the suture line)
2. Incise the outer prepuce circumferentially just proximal to the coronal sulcus
3. Incise the inner prepuce circumferentially 5–8 mm proximal to the coronal sulcus on the mucosal side
4. Excise the sleeve of foreskin between the two incision lines
5. Achieve haemostasis with diathermy or ligation of the frenular artery
6. Approximate the skin edges with interrupted 3/0 or 4/0 absorbable sutures (e.g. Vicryl Rapide or chromic catgut)

The procedure takes 20–45 minutes under local anaesthesia (DPNB plus penile ring block at the base) or spinal/general anaesthesia. A light dressing is applied. Absorbable sutures do not require removal.

Preputioplasty (Foreskin-Sparing Alternative)

A Y-V-plasty or dorsal slit and widening procedure that widens the preputial opening without removing the foreskin. Appropriate for mild–moderate phimosis without BXO, preserving the foreskin for patients who wish to avoid circumcision.

The medical literature supports a range of benefits from male circumcision, with the magnitude of benefit varying by clinical context.

Treatment of Pathological Phimosis

Circumcision is curative for BXO-related phimosis. Resolution of the obstructive preputial opening eliminates urinary stream narrowing, recurrent secondary infections, pain during erection, and the risk of urethral meatal stenosis (if BXO extends to the meatus, concurrent meatoplasty is required). Cure rate is 100% for phimosis symptoms when adequate skin is excised.

Elimination of Balanoposthitis Recurrence

Recurrent balanoposthitis, both Candidal and bacterial, resolves completely in the vast majority of cases following circumcision. The moist, anaerobic sub-preputial environment that harbours pathogens is eliminated, dramatically reducing recurrence.

UTI Prevention in High-Risk Infants

For boys with vesicoureteric reflux or other obstructive uropathies, circumcision in infancy substantially reduces UTI risk and by extension, the risk of pyelonephritis-related renal scarring. In this specific population, the benefit-to-risk ratio is clearly favourable.

HIV Reduction in High-Prevalence Settings

A 60% reduction in female-to-male HIV transmission in circumcised men, demonstrated in three African RCTs, represents a major public health benefit in sub-Saharan Africa where HIV prevalence is high. The WHO and UNAIDS VMMC programme has circumcised over 27 million men in eastern and southern Africa since 2007, contributing to reduced HIV incidence in those regions.

Reduced HPV and HSV-2 Acquisition

Circumcised men have lower rates of HPV infection on the penile shaft (HPV 6, 11, 16, 18 — causative of genital warts and penile cancer), reduced risk of HSV-2 acquisition, and lower rates of chancroid. These STI prevention benefits have broader public health implications, including potential indirect reduction in cervical cancer rates in female partners.

Penile Hygiene

Circumcision eliminates smegma accumulation under the foreskin, which can be a source of secondary infection and malodour. This hygiene benefit is often cited by patients requesting elective adult circumcision.

Penile Cancer Prevention

Virtually no cases of penile squamous cell carcinoma occur in men circumcised in infancy. This is partly due to HPV elimination and partly due to elimination of phimosis (itself a risk factor for penile cancer). The absolute benefit in low-incidence countries is modest but real.

Circumcision is generally a safe procedure with a low complication rate, but complications do occur and patients (or parents) must be fully informed before consenting.

Bleeding

The most common complication. Minor bleeding from the frenular artery or wound edges occurs in approximately 1% of neonatal circumcisions and 2–3% of adult procedures. Most bleeding is controlled with direct pressure or diathermy. Haematoma requiring surgical drainage occurs in <0.5% of cases. Patients on anticoagulant or antiplatelet medication require peri-operative management of their anticoagulation.

Infection

Wound infection occurs in 0.5–1% of cases. Most infections are superficial and respond to topical antiseptics (dilute potassium permanganate soaks). Rare cases of deeper infection, meatal stenosis from infection, or necrotising fasciitis (extremely rare) have been reported. Sterile technique and appropriate post-operative wound care are the primary preventive measures.

Meatal Stenosis

In neonates, circumcision exposes the urinary meatus to ammonia in wet nappies/diapers. Recurrent ammoniacal meatitis can cause scarring and progressive narrowing of the urethral meatus. Meatal stenosis occurs in approximately 5–10% of circumcised boys and presents with a fine, high-velocity urinary stream deflected downward. Treatment is meatotomy (a minor office procedure under local anaesthesia).

Excessive Skin Removal

Removing too much shaft skin can cause painful tethering of the penile skin during erection. Conversely, too little skin removal can result in redundant foreskin and recurrent balanoposthitis. Careful pre-operative marking and technique selection minimise this risk. Revision circumcision is possible but complex.

Inadvertent Injury

Rare cases of glans injury, partial or complete glans amputation, and urethral injury have been reported with neonatal clamp devices (particularly Mogen clamp if used carelessly). These are rare (<1 in 10,000) but serious complications requiring immediate urological intervention.

Cosmetic Dissatisfaction

Some adult patients are dissatisfied with the cosmetic result — asymmetric skin removal, inclusion cysts along the suture line, or dysaesthesia (altered sensation) of the glans. These outcomes are more common with technically suboptimal procedures. Choosing a trained urologist and discussing aesthetic preferences pre-operatively reduces dissatisfaction.

Altered Sensitivity

The foreskin contains sensory nerve endings (Meissner's corpuscles) and the inner prepuce is highly innervated mucosal tissue. Some circumcised men report altered penile sensitivity. The evidence on whether circumcision consistently reduces sexual pleasure or function is mixed; large population studies show no significant difference in sexual satisfaction or erectile function between circumcised and uncircumcised men. However, individual experience varies.

Neonatal Pain

Without adequate analgesia, neonatal circumcision causes significant pain responses (crying, elevated cortisol, altered feeding, disturbed sleep). A dorsal penile nerve block (DPNB) with 1% lidocaine is the most effective analgesic and should be used for all neonatal circumcisions. EMLA cream plus a sucrose pacifier provides additional comfort. Restraint boards (circumcision boards) used without analgesia are ethically unacceptable.

Post-operative care for circumcision is straightforward, and most patients recover without significant issues. Instructions differ between neonates and adults.

Neonatal Post-Circumcision Care

• Apply petroleum jelly (Vaseline) generously to the circumcision site at every nappy change for 5–7 days to prevent the exposed glans from sticking to the nappy and causing discomfort
• Mild redness, swelling, and a small amount of blood spotting on the nappy in the first 24 hours is normal
• A small amount of yellow exudate on the glans in the first few days represents normal healing, not infection
• The Plastibell ring (if used) should fall off within 5–10 days on its own; do not pull it off
• Seek urgent medical attention if: persistent bleeding that does not stop with 5 minutes of firm pressure; no urine passed within 6–8 hours post-procedure; fever; signs of spreading redness or malodour

Adult Post-Circumcision Care

• A light dressing is usually removed at 24–48 hours or when soaked through
• Gentle daily bathing with warm water; dilute potassium permanganate soaks (1:10,000) can reduce swelling and keep the wound clean
• Pain management: regular paracetamol 1g 4 times daily and ibuprofen 400 mg 3 times daily (if no contraindications) for 5–7 days. Prescribe opiate analgesia only if needed
• Absorbable sutures dissolve in 10–21 days; if non-absorbable sutures were used, they are removed at 7–10 days post-surgery
• Avoid sexual activity or masturbation for 4–6 weeks to allow the suture line to heal fully
• Oedema of the penile shaft and glans is normal and may be significant in the first 7–14 days; it resolves spontaneously
• Penile erections in the early post-operative period can be painful and may cause wound disruption; low-dose diazepam 2 mg at night for the first week can help reduce nocturnal erections in adult patients

Follow-Up Appointments

• Review at 4–6 weeks post-operatively to assess wound healing, meatal calibre, and cosmetic result
• For BXO-related circumcision: review at 6 months as BXO can extend to the glans and meatus, requiring ongoing topical steroid treatment or meatal surgery
• Children: review at 6–8 weeks post-operatively to assess meatal calibre and check for meatal stenosis development

The cost of circumcision varies considerably by clinical indication, patient age, anaesthesia type, and geographic location.

By Age and Setting

• Neonatal circumcision (USA): USD 150–600 in hospital (hospital fee + physician fee); USD 50–200 if performed in a physician's office. Often covered by Medicaid in states where medical indication is established; some state Medicaid programmes do not cover elective neonatal circumcision
• Paediatric circumcision under GA (USA): USD 1,500–4,000 including surgeon, anaesthetist, and ambulatory surgery centre fees
• Adult circumcision under local anaesthesia (USA): USD 1,000–3,000 in an outpatient surgical centre; USD 500–1,500 in a physician's office setting

By Country (Medical Tourism)

• India: INR 8,000–30,000 (USD 100–370) for adult circumcision at a private hospital; paediatric circumcision under GA INR 15,000–50,000 (USD 180–600)
• Thailand: USD 200–600 for adult circumcision; performed at international hospitals in Bangkok and Phuket by urologists trained in Western institutions
• Turkey: USD 150–500 at private urology clinics; Turkey has one of the highest circumcision rates globally (>98%) and extensive surgical expertise
• Israel: Religious circumcision (brit milah) is widely available; medical circumcisions at low cost through the national health system

Anaesthesia Costs

Neonatal circumcision with a DPNB adds minimal cost. Adult circumcision under spinal anaesthesia adds anaesthetist fees (USD 500–1,500 in the USA). General anaesthesia adds further cost. Local anaesthesia-only adult circumcision in a clinic setting is the most cost-effective option.

Insurance Coverage

When circumcision is performed for a clear medical indication (phimosis with BXO, recurrent UTIs, paraphimosis, recurrent balanoposthitis), it is generally covered by health insurance in the UK (NHS), Australia (Medicare with specialist referral), Canada, and most European countries. Elective or cosmetic circumcision is typically not covered.

For most medical indications, non-surgical alternatives should be tried before circumcision, particularly in children where phimosis is frequently physiological.

Topical Corticosteroids for Phimosis

The first-line treatment for paediatric phimosis (non-BXO) is a potent topical corticosteroid applied to the preputial opening twice daily for 4–8 weeks. Options include betamethasone 0.05%, mometasone furoate 0.1%, or clobetasol propionate 0.05%. Success rates of 70–90% in achieving full retraction have been reported in clinical trials. Steroid creams are safe for use on the prepuce with no systemic absorption risk at typical doses. This approach is cost-effective and preserves the foreskin. BXO does not respond to topical steroids.

Preputioplasty

A surgical procedure that widens the preputial opening without full foreskin excision. Indicated when topical steroids have failed but the patient (or parents) prefer foreskin preservation. Techniques include dorsal slit and widening, Y-V plasty, and triple incision plasty. Success rates are good for mild to moderate phimosis but lower than circumcision for BXO.

Antifungal/Antibiotic Treatment for Balanoposthitis

Most episodes of balanoposthitis respond to topical antifungals (clotrimazole 1% cream twice daily for 2 weeks for Candidal infection) or topical antibiotics (fusidic acid, mupirocin). Identification of the causative organism (swab for culture) guides specific treatment. Circumcision is considered only after adequate treatment of individual episodes fails or recurrence is frequent (≥3 episodes per year).

HIV Prevention Alternatives

In high-HIV-prevalence settings where VMMC is recommended, circumcision is most effective when combined with consistent condom use, HIV testing and counselling, antiretroviral therapy (ART) for positive partners, and PrEP (pre-exposure prophylaxis with tenofovir/emtricitabine). Circumcision alone is not sufficient HIV prevention and does not eliminate transmission risk.

HPV Vaccination

Prophylactic HPV vaccination (Gardasil 9, covering HPV types 6, 11, 16, 18, 31, 33, 45, 52, 58) in boys aged 9–12 years provides protection against HPV-related penile cancer, genital warts, and anal cancer, partially overlapping the HPV-related benefits of circumcision. Vaccination does not replace circumcision in medical indications but is an important complementary preventive strategy.

Watchful Waiting for Neonatal Non-Retractile Foreskin

Non-retractile foreskin in infancy and childhood is physiological and not an indication for circumcision or any intervention. Parents and practitioners should be reassured that spontaneous retractility develops in the vast majority of boys by adolescence. Forceful retraction of a non-retractile foreskin is harmful and should be avoided.